Trial Profile
Optimal Blood Management in Elective Orthopaedic Surgery: The Transfusion "Op Maat" (TOMaat) Study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Feb 2020
Price :
$35
*
At a glance
- Drugs Epoetin alfa (Primary) ; Epoetin beta (Primary)
- Indications Perioperative haemorrhage
- Focus Therapeutic Use
- Acronyms TOMaat
- 08 May 2012 Planned patient number is 2250 according to Netherlands Trial Register.
- 08 May 2012 New source identified and integrated (Netherlands Trial Register; NTR303).
- 02 Nov 2009 New trial record